Heterologous SARS-CoV-2 spike protein booster elicits durable and broad antibody responses against the receptor-binding domain

T Takano, T Sato, R Kotaki, S Moriyama… - Nature …, 2023 - nature.com
The immunogenicity of mRNA vaccines has not been well studied when compared to
different vaccine modalities in the context of additional boosters. Here we show that …

Kinetic of the antibody response following AddaVax-adjuvanted immunization with recombinant influenza antigens

TM Ross, N Gokanapudi, P Ge, H Shi, RA Richardson… - Vaccines, 2022 - mdpi.com
Notwithstanding the current SARS-CoV-2 pandemic, influenza virus infection still represents
a global health concern in terms of hospitalizations and possible pandemic threats. The …

[HTML][HTML] Heterologous booster immunization with SARS-CoV-2 spike protein after mRNA vaccine elicits durable and broad antibody responses

T Takano, T Sato, R Kotaki, S Moriyama, M Shinoda… - 2022 - europepmc.org
Although mRNA vaccines are more immunogenic than other vaccine modalities in primary
series vaccination, their immunogenicity has not been well compared to different vaccine …

Functional and Binding H1N1pdm09-Specific Antibody Responses in Occasionally and Repeatedly Vaccinated Healthcare Workers: A Five-Year Study (2009-2014)

H Amdam, A Madsen, F Zhou, A Bansal… - Frontiers in …, 2021 - frontiersin.org
Background In 2009, a novel influenza A/H1N1pdm09 emerged and caused a pandemic.
This strain continued to circulate and was therefore included in the seasonal vaccines up to …